Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases

Hiromi Suzuki; Atsushi Hatamochi; Michio Hasikabe; Soji Yamazaki; Motohiko Tamura; Hiromi Ishihama; Shinichiro Miyoshi

doi:10.2336/nishinihonhifu.66.599

Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases

Hiromi Suzuki, Atsushi Hatamochi, Michio Hasikabe, Soji Yamazaki, Motohiko Tamura, Hiromi Ishihama, Shinichiro Miyoshi

Graduate School of Medicine Dentistry and Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Gefitinib (Iressa®) is a new anticancer agent against lung cancer that acts by inhibiting signal transduction of the growth factor receptor. We describe six patients receiving gefitinib (250mg/day) who developed an acne-like eruption consisting of follicular papules and pustules on their faces, chests and/or backs. A histopathological examination of one patient revealed an inflammatory cell infiltration around the hair follicles.

Original language	English
Pages (from-to)	599-601
Number of pages	3
Journal	Nishinihon Journal of Dermatology
Volume	66
Issue number	6
DOIs	https://doi.org/10.2336/nishinihonhifu.66.599
Publication status	Published - Dec 1 2004

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2336/nishinihonhifu.66.599

Cite this

@article{c5d529baa6bd4d818e089189b877f5d5,

title = "Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases",

abstract = "Gefitinib (Iressa{\textregistered}) is a new anticancer agent against lung cancer that acts by inhibiting signal transduction of the growth factor receptor. We describe six patients receiving gefitinib (250mg/day) who developed an acne-like eruption consisting of follicular papules and pustules on their faces, chests and/or backs. A histopathological examination of one patient revealed an inflammatory cell infiltration around the hair follicles.",

author = "Hiromi Suzuki and Atsushi Hatamochi and Michio Hasikabe and Soji Yamazaki and Motohiko Tamura and Hiromi Ishihama and Shinichiro Miyoshi",

year = "2004",

month = dec,

day = "1",

doi = "10.2336/nishinihonhifu.66.599",

language = "English",

volume = "66",

pages = "599--601",

journal = "Nishinihon Journal of Dermatology",

issn = "0386-9784",

publisher = "Kyushu University, Faculty of Science",

number = "6",

}

TY - JOUR

T1 - Acneiform follicular eruption in patients treated with Gefitinib

T2 - Report of six cases

AU - Suzuki, Hiromi

AU - Hatamochi, Atsushi

AU - Hasikabe, Michio

AU - Yamazaki, Soji

AU - Tamura, Motohiko

AU - Ishihama, Hiromi

AU - Miyoshi, Shinichiro

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Gefitinib (Iressa®) is a new anticancer agent against lung cancer that acts by inhibiting signal transduction of the growth factor receptor. We describe six patients receiving gefitinib (250mg/day) who developed an acne-like eruption consisting of follicular papules and pustules on their faces, chests and/or backs. A histopathological examination of one patient revealed an inflammatory cell infiltration around the hair follicles.

AB - Gefitinib (Iressa®) is a new anticancer agent against lung cancer that acts by inhibiting signal transduction of the growth factor receptor. We describe six patients receiving gefitinib (250mg/day) who developed an acne-like eruption consisting of follicular papules and pustules on their faces, chests and/or backs. A histopathological examination of one patient revealed an inflammatory cell infiltration around the hair follicles.

UR - http://www.scopus.com/inward/record.url?scp=11144281774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144281774&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.66.599

DO - 10.2336/nishinihonhifu.66.599

M3 - Article

AN - SCOPUS:11144281774

SN - 0386-9784

VL - 66

SP - 599

EP - 601

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

IS - 6

ER -

Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this